UBS Group
PHIO icon

UBS Group’s Phio Pharmaceuticals PHIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-103
Closed -$134 9244
2025
Q1
$134 Sell
103
-2,294
-96% -$2.98K ﹤0.01% 8608
2024
Q4
$4.32K Buy
2,397
+712
+42% +$1.28K ﹤0.01% 7521
2024
Q3
$5.81K Sell
1,685
-762
-31% -$2.63K ﹤0.01% 6816
2024
Q2
$1.69K Buy
2,447
+1,089
+80% +$753 ﹤0.01% 7358
2024
Q1
$923 Buy
+1,358
New +$923 ﹤0.01% 7131
2023
Q2
Sell
-207
Closed -$1.16K 8260
2023
Q1
$1.16K Sell
207
-22,822
-99% -$128K ﹤0.01% 7693
2022
Q4
$8.52K Buy
+23,029
New +$8.52K ﹤0.01% 7572
2022
Q2
Sell
-2,685
Closed -$2K 9596
2022
Q1
$2K Sell
2,685
-4,315
-62% -$3.21K ﹤0.01% 8597
2021
Q4
$7K Buy
7,000
+759
+12% +$759 ﹤0.01% 8035
2021
Q3
$13K Buy
6,241
+4,864
+353% +$10.1K ﹤0.01% 6538
2021
Q2
$3K Buy
+1,377
New +$3K ﹤0.01% 7718
2021
Q1
Sell
-5,623
Closed -$15K 8145
2020
Q4
$15K Buy
5,623
+5,057
+893% +$13.5K ﹤0.01% 6149
2020
Q3
$1K Sell
566
-10,593
-95% -$18.7K ﹤0.01% 6933
2020
Q2
$24K Buy
11,159
+10,596
+1,882% +$22.8K ﹤0.01% 5590
2020
Q1
$1K Sell
563
-44,846
-99% -$79.7K ﹤0.01% 6858
2019
Q4
$427K Buy
45,409
+13,714
+43% +$129K ﹤0.01% 4021
2019
Q3
$9K Sell
31,695
-5,848
-16% -$1.66K ﹤0.01% 6252
2019
Q2
$14K Buy
37,543
+13,670
+57% +$5.1K ﹤0.01% 5976
2019
Q1
$11K Buy
+23,873
New +$11K ﹤0.01% 5916
2018
Q4
Sell
-1,181
Closed -$1K 7178
2018
Q3
$1K Sell
1,181
-175
-13% -$148 ﹤0.01% 6912
2018
Q2
$3K Sell
1,356
-2,506
-65% -$5.54K ﹤0.01% 6708
2018
Q1
$12K Sell
3,862
-11,479
-75% -$35.7K ﹤0.01% 5879
2017
Q4
$9K Buy
+15,341
New +$9K ﹤0.01% 6126
2017
Q3
Sell
-33,389
Closed -$20K 6871
2017
Q2
$20K Buy
33,389
+21,051
+171% +$12.6K ﹤0.01% 5363
2017
Q1
$10K Buy
+12,338
New +$10K ﹤0.01% 5693
2016
Q4
Sell
-8,868
Closed -$16K 6859
2016
Q3
$16K Buy
8,868
+6,941
+360% +$12.5K ﹤0.01% 5571
2016
Q2
$5K Sell
1,927
-20,632
-91% -$53.5K ﹤0.01% 6224
2016
Q1
$6K Buy
+22,559
New +$6K ﹤0.01% 6067
2015
Q2
Sell
-87
Closed 6856
2015
Q1
$0 Buy
+87
New ﹤0.01% 6756